Status:
WITHDRAWN
ADOPT: Improving Diagnosis of Pulmonary Hypertension With AI and Echo
Lead Sponsor:
Royal United Hospitals Bath NHS Foundation Trust
Collaborating Sponsors:
Janssen Research & Development, LLC
Royal Free Hospital NHS Foundation Trust
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary Hypertension (PH) is a condition caused by high blood pressure in the blood vessels that carry blood to the lungs. It can cause severe breathlessness and failure of the right side of the hea...
Detailed Description
In this study the investigators will gather retrospective echo images from 5 specialist PH hospitals across the UK (Royal Free Hospital NHS FT; Sheffield Teaching Hospitals NHS FT; Royal Papworth Hosp...
Eligibility Criteria
Inclusion
- Patients aged ≥18
- Have undergone a transthoracic echo and right heart catheter as part of their routine clinical care.
Exclusion
- Patients aged \<18
- Known or suspected congenital heart disease
- Patient opted out of allowing their information to be used for research and planning (via the national data opt-out choice).
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06145880
Start Date
December 1 2023
End Date
December 1 2025
Last Update
November 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom, BA1 3NG